Logotype for The Chemours Company

The Chemours Company (CC) Q3 2026 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for The Chemours Company

Q3 2026 earnings summary

5 Nov, 2026

Executive summary

  • Q3 net sales rose 3% YoY to $1.54B; Adjusted EBITDA increased 6% to $200M, led by TT pricing and APM growth, partly offset by TSS weakness and higher costs.

  • GAAP net income was $196M, or $1.29/share, including $150M of PFAS insurance proceeds; Adjusted Net Income was $31M.

  • Execution included debt reduction, cost and operating initiatives, environmental settlements, and completion of the Kuan Yin land sale.

Financial highlights

  • Net sales were $1.54B, up $45M YoY and down $51M QoQ; pricing rose 5%, volumes fell 2%, and currency was a slight headwind.

  • Adjusted EBITDA was $200M, up $11M YoY and down $47M QoQ; adjusted net income was $31M and adjusted diluted EPS was $0.21.

  • Operating cash flow was $149M, capex $51M, and free cash flow $98M; Q3 free-cash-flow conversion was 49% versus 56% a year earlier.

  • GAAP net income of $196M included $150M of PFAS insurance proceeds and Kuan Yin land-sale gains; Q3 COGS rose 4% amid higher unit costs and lower production rates.

  • Nine-month net sales were $4.51B; net loss was $107M, including a $307M tax provision and substantial environmental and litigation charges.

Outlook and guidance

  • FY2026 net sales are expected to grow ~2%; Adjusted EBITDA guidance is $775M–$800M, capex $220M–$230M, free-cash-flow conversion 15%–20%, and net leverage below 4.2x.

  • Q4 net sales are expected to decline 5%–10% sequentially; Adjusted EBITDA is forecast at $160M–$185M, with positive free cash flow.

  • Q4 TSS sales are expected to decline high-teens to low-twenties sequentially, with Adjusted EBITDA of $105M–$115M; TT sales are expected down high-single digits to low-teens, with EBITDA of $60M–$65M.

  • Q4 APM sales are expected to rise low- to mid-teens sequentially, with Adjusted EBITDA of $40M–$45M, supported by Performance Solutions orders.

  • Earnings growth is expected in 2027 despite macro uncertainty; expected environmental remediation spending over three years is $227M at five significant sites and $63M at other sites.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more

Latest events from The Chemours Company